Records containing: Ocular Hypertension

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2016-03-14
  The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
• CLINICAL_TRIALS study record update · 2016-02-25
  A 28-day Double-masked, Randomized, Parallel-group, Active Controlled Study of ONO-9054 Ophthalmic Solution in Subjects With Ocular Hypertension (OHT) or Open-angle Glaucoma (OAG)
• CLINICAL_TRIALS study record update · 2016-01-14
  ClinicalTrials.gov study NCT02097719
• CLINICAL_TRIALS study record update · 2015-12-29
  A 6-Week Proof-of-Concept Study Evaluating the Safety and IOP-Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
• CLINICAL_TRIALS study record update · 2015-12-09
  ClinicalTrials.gov study NCT01999348
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2015-11-30
  ClinicalTrials.gov study NCT01881126
• CLINICAL_TRIALS study record update · 2015-11-17
  ClinicalTrials.gov study NCT02105285
• CLINICAL_TRIALS study record update · 2015-11-17
  ClinicalTrials.gov study NCT02105272
• CLINICAL_TRIALS study record update · 2015-11-09
  ClinicalTrials.gov study NCT01217606
• CLINICAL_TRIALS study record update · 2015-10-29
  Intraocular Pressure and Tolerability Study of Preservative Free Bimatoprost 0.03% Unit Dose (BUDPF) or Preservative Free Latanoprost 0.005% Unit Dose (LUDPF) (Monoprost®) in Patients With Ocular Hypertension or Glaucoma: A Randomized, Single Masked, 3 Month Cross-over, Investigator Led, European Multicentre Trial (SPORT)
• CLINICAL_TRIALS study record update · 2015-10-26
  ClinicalTrials.gov study NCT01814761
• CLINICAL_TRIALS study record update · 2015-09-21
  ClinicalTrials.gov study NCT02348476
• CLINICAL_TRIALS study record update · 2015-09-14
  A Phase 1/2a, Randomized, Parallel-group, Double-masked, Vehicle-controlled, Dose-frequency Escalation Study to Evaluate the Safety, Tolerability, and Intraocular Pressure (IOP)-Lowering Efficacy of Topically Administered LX7101 in Subjects Diagnosed With Primary Open-angle Glaucoma (POAG) or Ocular Hypertension (OHT)
• CLINICAL_TRIALS study record update · 2015-07-29
  ClinicalTrials.gov study NCT01111890
• CLINICAL_TRIALS study record update · 2015-07-21
  ClinicalTrials.gov study NCT01976624
• CLINICAL_TRIALS study record update · 2015-07-20
  Investigation of the Effect of Travoprost Ophthalmic Solution of Lowering Intraocular Pressure in Patients With Normal Tension Glaucoma
• CLINICAL_TRIALS study record update · 2015-07-14
  Assessing the Efficacy and Tolerability of TRAVATAN® Solution Without BAK, Containing Polyquad® Preservative (Travoprost 0.004%) Versus LUMIGAN® 0.01% Solution With BAK (Bimatoprost 0.01%) in Treatment Naïve Patients With Ocular Hypertension or Open Angle Glaucoma
• CLINICAL_TRIALS study record update · 2015-07-09
  The Effect of Omega-3 Fatty Acid Supplementation on Intraocular Pressure & Ocular Surface
• CLINICAL_TRIALS study record update · 2015-07-07
  Central Corneal Thickness and 24-hour Fluctuation of Intraocular Pressure
• CLINICAL_TRIALS study record update · 2015-06-11
  A Multi-Site Questionnaire-Based Study to Assess Attitudes Regarding Current IOP-Lowering Eye Drops and Products in Development for Sustained Release of Medication in Glaucomatous and Ocular Hypertensive Subjects
• CLINICAL_TRIALS study record update · 2015-06-08
  Additive Effect of Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination as Adjunctive Therapy to a Prostaglandin Analogue
• CLINICAL_TRIALS study record update · 2015-05-28
  ClinicalTrials.gov study NCT01853085
• CLINICAL_TRIALS study record update · 2015-05-15
  A Double-masked Study of DE-111 Ophthalmic Solution Versus Timolol Ophthalmic Solution 0.5% in Patients With Primary Open Angle Glaucoma or Ocular Hypertension - Phase 3, Confirmatory Study -
• CLINICAL_TRIALS study record update · 2015-05-14
  A Double-masked Study of DE-111 Ophthalmic Solution Versus Tafluprost Ophthalmic Solution 0.0015% Alone and Concomitant Use of Tafluprost Ophthalmic Solution 0.0015% Plus Timolol Ophthalmic Solution 0.5% in Patients With Primary Open Angle Glaucoma or Ocular Hypertension -Phase 3, Confirmatory Study-
• CLINICAL_TRIALS study record update · 2015-05-14
  Additive Effect of Brinzolamide 1%/Brimonidine 0.2% Fixed Dose Combination As Adjunctive Therapy to Travoprost